CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in NSCLC

MLA

Ashley Horne, et al. “CONCORDE: A Phase Ib Platform Study of Novel Agents in Combination with Conventional Radiotherapy in NSCLC.” Lung Cancer, vol. 178, Apr. 2023, pp. S86–87. EBSCOhost, https://doi.org/10.1016/s0169-5002(23)00622-0.

APA

Ashley Horne, Sarah Brown, Vicky Coyle, Kevin Franks, Adam Hassani, Stephen Harrow, Matthew Hatton, Crispin Hiley, Jessica Kendall, Jamie Oughton, Paul Shaw, Fiona Walker, Huiqi Yang, Anthony Chalmers, Corinne Faivre-Finn, & Alastair Greystoke. (2023). CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in NSCLC. Lung Cancer, 178, S86–S87. https://doi.org/10.1016/s0169-5002(23)00622-0

Chicago

Ashley Horne, Sarah Brown, Vicky Coyle, Kevin Franks, Adam Hassani, Stephen Harrow, Matthew Hatton, et al. 2023. “CONCORDE: A Phase Ib Platform Study of Novel Agents in Combination with Conventional Radiotherapy in NSCLC.” Lung Cancer 178 (April): S86–87. doi:10.1016/s0169-5002(23)00622-0.